Physician profile
Brian K Solow
NPI 1689665036
$68,267.23
in general payments reported to CMS, 2019-2025
13 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,815 · 2020: $5,225 · 2021: $4,700 · 2022: $4,800 · 2023: $5,363 · 2024: $14K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $44K · Travel and Lodging: $1,329 · Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,982.19 |
| Travel and Lodging | $1,329.32 |
| Food and Beverage | $415.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $12,932.19 | 2023-2024 | |
| Allergan, INC. | $12,825.00 | 2019-2020 | |
| Alkermes, INC. | $11,019.74 | 2025 | |
| Incyte Corporation | $10,000.00 | 2025 | |
| Gilead Sciences, INC. | $4,300.00 | 2023-2024 | Biktarvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $4,065.00 | 2022-2023 | |
| Janssen Global Services, LLC | $3,120.00 | 2022 | |
| Johnson & Johnson Health Care Systems INC. | $3,000.00 | 2025 | Spravato |
| H. Lundbeck A S | $2,500.00 | 2021 | |
| Pharmacosmos Therapeutics INC. | $2,200.00 | 2021 | |
| Merck Sharp & Dohme LLC | $2,065.00 | 2025 | |
| Pfizer INC. | $215.38 | 2019 | |
| Sage Therapeutics, LLC | $24.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Solow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.